PEY11 ESTIMATING NET HEALTH BENEFITS OF VASCULAR ENDOTHELIAL GROWTH FACTOR (VEGF) INHIBITORS FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION (NV-AMD)
Abstract
Authors
AR Levy SM Szabo G Zlateva A Briggs A Pleil
AR Levy SM Szabo G Zlateva A Briggs A Pleil
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now